EP2897598A4 - Transdermal drug delivery device - Google Patents

Transdermal drug delivery device

Info

Publication number: EP2897598A4
Authority: EP; European Patent Office
Prior art keywords: delivery device; drug delivery; transdermal drug; transdermal; drug
Prior art date: 2012-09-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

EP13839377.2A

Other languages

German (de)

French (fr)

Other versions

EP2897598A1 (en

Inventor

Jiansheng Tang

Shenshen Cai

Bhushan Katkade

William Schumacher

Kenneth J Miller

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Mylan Inc

Original Assignee

Mylan Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-09-21

Filing date

2013-09-18

Publication date

2016-04-27

2013-09-18 Application filed by Mylan Inc filed Critical Mylan Inc

2015-07-29 Publication of EP2897598A1 publication Critical patent/EP2897598A1/en

2016-04-27 Publication of EP2897598A4 publication Critical patent/EP2897598A4/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Laminated Bodies (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP13839377.2A 2012-09-21 2013-09-18 Transdermal drug delivery device Ceased EP2897598A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13/624,390 US20140083878A1 (en)	2012-09-21	2012-09-21	Transdermal drug delivery device
PCT/US2013/060430 WO2014047191A1 (en)	2012-09-21	2013-09-18	Transdermal drug delivery device

Publications (2)

Publication Number	Publication Date
EP2897598A1 EP2897598A1 (en)	2015-07-29
EP2897598A4 true EP2897598A4 (en)	2016-04-27

Family

ID=50337825

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP13839377.2A Ceased EP2897598A4 (en)	2012-09-21	2013-09-18	Transdermal drug delivery device

Country Status (7)

Country	Link
US (1)	US20140083878A1 (en)
EP (1)	EP2897598A4 (en)
JP (1)	JP2015535827A (en)
AU (2)	AU2013318116A1 (en)
BR (1)	BR112015005944A2 (en)
CA (1)	CA2884108A1 (en)
WO (1)	WO2014047191A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH10228623A (en) *	1997-07-28	1998-08-25	Fuji Photo Film Co Ltd	Magnetic recording medium
ITMI20120031A1 (en) *	2012-01-13	2013-07-14	Altergon Sa	PACKAGING STRUCTURE FOR BIOMEDICAL FILMS
EP3129012A4 (en) *	2014-04-08	2017-10-11	Teikoku Pharma USA, Inc.	Rivastigmine transdermal compositions and methods of using the same
US20170042311A1 (en)	2014-10-21	2017-02-16	The Procter & Gamble Company	Method of Improving Skin Appearance
JP6176413B2 (en) *	2015-01-30	2017-08-09	東洋インキＳｃホールディングス株式会社	Patch
CN107427472B (en) *	2015-03-02	2021-04-30	久光制药株式会社	Adhesive patch
WO2017053489A1 (en) *	2015-09-25	2017-03-30	The Procter & Gamble Company	Precision applicator
CN108348788B (en) *	2015-10-22	2021-11-05	宝洁公司	Barrier patches for foamed films and methods of improving the appearance of skin
WO2017070078A1 (en) *	2015-10-22	2017-04-27	The Procter & Gamble Company	Barrier patch of a foamed film and methods of improving skin appearance
EP3565641B1 (en) *	2017-01-09	2021-06-23	The Procter & Gamble Company	Barrier patch with soluble film and methods of improving skin appearance
US10857076B2 (en) *	2017-01-09	2020-12-08	The Procter & Gamble Company	Barrier patch with soluble film and methods of improving skin appearance
US10751265B2 (en) *	2017-01-09	2020-08-25	The Procter & Gamble	Barrier patch with soluble film and methods of improving skin appearance
WO2018237214A1 (en)	2017-06-22	2018-12-27	The Procter & Gamble Company	Beauty care films including a water-soluble layer and a vapor-deposited coating
WO2019017266A1 (en) *	2017-07-19	2019-01-24	帝國製薬株式会社	Rivastigmine-containing percutaneous absorption-type preparation
WO2019183010A1 (en)	2018-03-19	2019-09-26	The Procter & Gamble Company	Method of making a barrier patch with soluble film
AU2019432306B2 (en) *	2019-03-01	2023-01-05	Nordiccan A/S	Tableted cannabinoid chewing gum with layered structure
CN110051825B (en) *	2019-05-29	2022-09-09	中国人民解放军陆军军医大学第一附属医院	Herpes zoster treatment patch
CA3146086A1 (en) *	2019-07-09	2021-01-14	Lts Lohmann Therapie-Systeme Ag	Transdermal therapeutic system comprising an active agent-containing layer comprising an acrylic polymer and a skin contact layer comprising a silicone gel adhesive
US11021300B2 (en)	2019-10-16	2021-06-01	Sonoco Development, Inc.	Flexible packaging with internal release
CN114569181B (en) *	2022-03-15	2023-10-13	上海交通大学医学院附属瑞金医院	Reduced Zhang Jiaodai and method for preparing same
CN116098878A (en) *	2023-01-04	2023-05-12	新领医药技术(深圳)有限公司	Stable transdermal drug delivery kit, preparation method and application thereof
WO2024145846A1 (en) *	2023-01-04	2024-07-11	新领医药技术(深圳)有限公司	Stable transdermal drug delivery kit, preparation method therefor, and use thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001030316A2 (en) *	1999-10-28	2001-05-03	3M Innovative Properties Company	Transdermal drug delivery devices comprising (r)-(z)-1-azabicyclo(2.2.1)heptan-3-one, 0-(3(3-methoxyphenyl)-2-propynyl)oxime
US20020168401A1 (en) *	2000-03-14	2002-11-14	Noven Pharmaceuticals, Inc.	Packaging system for transdermal drug delivery systems
US20070128263A1 (en) *	2005-12-01	2007-06-07	Gargiulo Paul M	Transdermal therapeutic system
WO2012012417A1 (en) *	2010-07-21	2012-01-26	3M Innovative Properties Company	Transdermal adhesive compositions, devices, and methods
US20120031047A1 (en) *	2010-08-03	2012-02-09	Hisamitsu Pharmaceutical Co., Inc.	Method for storing transdermally/transmucosally absorbable preparation and package of transdermally/transmucosally absorbable preparation
WO2013128562A1 (en) *	2012-02-28	2013-09-06	ニチバン株式会社	Adhesive skin patch
EP2898882A1 (en) *	2012-09-20	2015-07-29	SK Chemicals Co., Ltd.	Medicine having improved rivastigmine stability

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4020144A1 (en) *	1990-06-25	1992-01-09	Lohmann Therapie Syst Lts	Patches for topical or transdermal drug delivery - with adhesive layer contg. polyacrylate adhesive and film former
US5698217A (en) *	1995-05-31	1997-12-16	Minnesota Mining And Manufacturing Company	Transdermal drug delivery device containing a desiccant
US6316023B1 (en) *	1998-01-12	2001-11-13	Novartis Ag	TTS containing an antioxidant
GB2336310B (en) *	1998-04-14	2003-09-10	Stowic Resources Ltd	Method of manufacturing transdermal patches
DE19959913A1 (en) *	1999-12-11	2001-06-28	Lohmann Therapie Syst Lts	Transdermal system for the treatment of migraines containing acetylsalicylic acid
JP4924837B2 (en) *	2005-04-20	2012-04-25	千寿製薬株式会社	Transdermal absorption preparation
CN101486401B (en) *	2007-12-14	2012-06-20	日东电工株式会社	Patch package structure
JP6083734B2 (en) *	2009-12-22	2017-02-22	リュイェファーマアーゲーＬｕｙｅＰｈａｒｍａＡＧ	Transdermal therapeutic system for administering rivastigmine or a derivative thereof

2012
- 2012-09-21 US US13/624,390 patent/US20140083878A1/en not_active Abandoned
2013
- 2013-09-18 WO PCT/US2013/060430 patent/WO2014047191A1/en active Application Filing
- 2013-09-18 BR BR112015005944A patent/BR112015005944A2/en not_active Application Discontinuation
- 2013-09-18 AU AU2013318116A patent/AU2013318116A1/en not_active Abandoned
- 2013-09-18 EP EP13839377.2A patent/EP2897598A4/en not_active Ceased
- 2013-09-18 JP JP2015533155A patent/JP2015535827A/en active Pending
- 2013-09-18 CA CA2884108A patent/CA2884108A1/en not_active Abandoned
2018
- 2018-05-07 AU AU2018203157A patent/AU2018203157A1/en not_active Abandoned

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001030316A2 (en) *	1999-10-28	2001-05-03	3M Innovative Properties Company	Transdermal drug delivery devices comprising (r)-(z)-1-azabicyclo(2.2.1)heptan-3-one, 0-(3(3-methoxyphenyl)-2-propynyl)oxime
US20020168401A1 (en) *	2000-03-14	2002-11-14	Noven Pharmaceuticals, Inc.	Packaging system for transdermal drug delivery systems
US20070128263A1 (en) *	2005-12-01	2007-06-07	Gargiulo Paul M	Transdermal therapeutic system
WO2012012417A1 (en) *	2010-07-21	2012-01-26	3M Innovative Properties Company	Transdermal adhesive compositions, devices, and methods
US20120031047A1 (en) *	2010-08-03	2012-02-09	Hisamitsu Pharmaceutical Co., Inc.	Method for storing transdermally/transmucosally absorbable preparation and package of transdermally/transmucosally absorbable preparation
WO2013128562A1 (en) *	2012-02-28	2013-09-06	ニチバン株式会社	Adhesive skin patch
EP2821070A1 (en) *	2012-02-28	2015-01-07	Nichiban Co. Ltd.	Adhesive skin patch
EP2898882A1 (en) *	2012-09-20	2015-07-29	SK Chemicals Co., Ltd.	Medicine having improved rivastigmine stability

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2014047191A1 *

Also Published As

Publication number	Publication date
EP2897598A1 (en)	2015-07-29
WO2014047191A4 (en)	2014-05-15
WO2014047191A1 (en)	2014-03-27
JP2015535827A (en)	2015-12-17
BR112015005944A2 (en)	2017-07-04
AU2013318116A1 (en)	2015-04-02
CA2884108A1 (en)	2014-03-27
AU2018203157A1 (en)	2018-05-24
US20140083878A1 (en)	2014-03-27

Publication	Publication Date	Title
HK1208387A1 (en)	2016-03-04	Drug delivery device
HK1208388A1 (en)	2016-03-04	Drug delivery device
EP2897598A4 (en)	2016-04-27	Transdermal drug delivery device
SI3081249T1 (en)	2021-03-31	Drug delivery device
HK1206655A1 (en)	2016-01-15	Drug delivery device
IL239527A0 (en)	2015-08-31	Medicament delivery device
HK1206654A1 (en)	2016-01-15	Drug delivery device
EP2812069A4 (en)	2016-03-09	Transdermal delivery device
HK1213503A1 (en)	2016-07-08	Drug delivery medical device
EP2961471A4 (en)	2017-04-05	Transdermal drug delivery device
EP2862588A4 (en)	2015-07-29	Drug injection device
HK1200388A1 (en)	2015-08-07	Fixed-dose medicament delivery device
ZA201406682B (en)	2015-11-25	Transdermal delivery devices
PL2878330T3 (en)	2017-01-31	Devices for transdermal drug delivery
AP2015008525A0 (en)	2015-06-30	Transdermal delivery system
IL235163B (en)	2018-08-30	Medicament delivery device
ZA201306604B (en)	2014-05-28	Drug delivery device
HK1205702A1 (en)	2015-12-24	Drug delivery device
GB201202091D0 (en)	2012-03-21	Drug delivery apparatus
HK1202826A1 (en)	2015-10-09	Medicament delivery devices
IL237077B (en)	2019-11-28	Substance delivery device
HK1202465A1 (en)	2015-10-02	Drug delivery device
HK1211246A1 (en)	2016-05-20	Drug delivery device
HK1205704A1 (en)	2015-12-24	Drug delivery device
HUE049546T2 (en)	2020-09-28	Drug delivery device

Legal Events

Date	Code	Title	Description
2015-06-26	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2015-07-29	17P	Request for examination filed	Effective date: 20150413
2015-07-29	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2015-07-29	AX	Request for extension of the european patent	Extension state: BA ME
2015-12-30	DAX	Request for extension of the european patent (deleted)
2016-04-27	RA4	Supplementary search report drawn up and despatched (corrected)	Effective date: 20160330
2016-04-27	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 9/70 20060101AFI20160322BHEP Ipc: A61F 13/02 20060101ALI20160322BHEP
2016-12-16	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2017-01-18	R17P	Request for examination filed (corrected)	Effective date: 20150413
2017-11-24	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2017-12-27	17Q	First examination report despatched	Effective date: 20171122
2019-12-10	REG	Reference to a national code	Ref country code: DE Ref legal event code: R003
2020-03-13	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED
2020-04-15	18R	Application refused	Effective date: 20191210